Impact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella review

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-04-21 DOI:10.1002/prp2.1195

Olalla Montero Pérez, Fernando Salazar González, Ernesto Sánchez Gómez, Concepción Pérez Guerrero

{"title":"Impact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella review","authors":"Olalla Montero Pérez, Fernando Salazar González, Ernesto Sánchez Gómez, Concepción Pérez Guerrero","doi":"10.1002/prp2.1195","DOIUrl":null,"url":null,"abstract":"Abstract Recent systematic reviews suggest that pharmacists' interventions in asthma patients have a positive impact on health‐related outcomes. Nevertheless, the association is not well established, and the role of clinical pharmacists is poorly represented. The aim of this overview of systematic reviews is to identify published systematic reviews assessing the impact of pharmacists' interventions on health‐related outcomes measured in asthma patients. PubMed, Embase, Scopus, and Cochrane Library were searched from inception to December 2022. Systematic reviews of all study designs and settings were included. Methodological quality was assessed using AMSTAR 2. Two investigators performed study selection, quality assessment and data collection independently. Nine systematic reviews met the inclusion criteria. Methodological quality was rated as high in one, low in two, and critically low in six. Reviews included 51 primary studies reporting mainly quality of life, asthma control, lung capacity, and therapeutic adherence. Only four studies were carried out in a hospital setting and only two reviews stated the inclusion of severe asthma patients. The quality of the systematic reviews was generally low, and this was the major limitation of this overview of systematic reviews. However, solid evidence supports that pharmaceutical care improves health‐related outcomes in asthma patients.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"106 47","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/prp2.1195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract Recent systematic reviews suggest that pharmacists' interventions in asthma patients have a positive impact on health‐related outcomes. Nevertheless, the association is not well established, and the role of clinical pharmacists is poorly represented. The aim of this overview of systematic reviews is to identify published systematic reviews assessing the impact of pharmacists' interventions on health‐related outcomes measured in asthma patients. PubMed, Embase, Scopus, and Cochrane Library were searched from inception to December 2022. Systematic reviews of all study designs and settings were included. Methodological quality was assessed using AMSTAR 2. Two investigators performed study selection, quality assessment and data collection independently. Nine systematic reviews met the inclusion criteria. Methodological quality was rated as high in one, low in two, and critically low in six. Reviews included 51 primary studies reporting mainly quality of life, asthma control, lung capacity, and therapeutic adherence. Only four studies were carried out in a hospital setting and only two reviews stated the inclusion of severe asthma patients. The quality of the systematic reviews was generally low, and this was the major limitation of this overview of systematic reviews. However, solid evidence supports that pharmaceutical care improves health‐related outcomes in asthma patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

哮喘患者的药物治疗对健康相关结果的影响：综述

摘要近期的系统综述表明，药剂师对哮喘患者的干预对健康相关结果有积极影响。然而，这种关联尚未得到充分证实，临床药剂师的作用也鲜有体现。本系统综述旨在确定已发表的系统综述，评估药剂师干预对哮喘患者健康相关结果的影响。我们检索了 PubMed、Embase、Scopus 和 Cochrane 图书馆从开始到 2022 年 12 月的所有文献。所有研究设计和研究环境的系统综述均被纳入。方法学质量采用 AMSTAR 2 进行评估。两名研究人员独立完成了研究选择、质量评估和数据收集工作。九篇系统综述符合纳入标准。方法学质量被评为高的有 1 篇，低的有 2 篇，极低的有 6 篇。综述包括 51 项主要报告生活质量、哮喘控制、肺活量和治疗依从性的主要研究。只有四项研究是在医院环境中进行的，只有两篇综述说明纳入了重症哮喘患者。系统综述的质量普遍较低，这也是本系统综述的主要局限性。不过，有确凿证据表明，药物治疗可改善哮喘患者的健康相关结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464

期刊介绍： ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.